EMV Relative Valuation - EMvision Medical Devices Ltd

Watchlist Manager

Watchlist

Price: 1.55 AUD Market Closed

Market Cap: AU$144.1m

	EMvision Medical Devices Ltd ASX:EMV	AU
	Elite Advanced Laser Corp TWSE:3450	TW
T	Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SGX:T14	CN

Multiples-Based Value

The Multiples-Based Value of one EMV stock under the Base Case scenario is 0.15 AUD. Compared to the current market price of 1.55 AUD, EMvision Medical Devices Ltd is Overvalued by 90%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

EMV Multiples-Based Value

Base Case

Overvaluation 90%

Multiples-Based Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
AU	EMvision Medical Devices Ltd ASX:EMV	144.1m AUD	25.6	-14.7	-14.3	-14.3
US	Abbott Laboratories NYSE:ABT	180.6B USD	4.1	27.7	15.9	21.8
US	Intuitive Surgical Inc NASDAQ:ISRG	160.7B USD	16	56.3	42.6	52.3
US	Stryker Corp NYSE:SYK	125.2B USD	5	38.6	19.7	23.9
IE	Medtronic PLC NYSE:MDT	111.8B USD	3.2	24.2	13.4	19.5
US	Boston Scientific Corp NYSE:BSX	102.6B USD	5.1	35.4	20.8	28
US	Edwards Lifesciences Corp NYSE:EW	46.1B USD	7.6	43	23.6	25.8
DE	Siemens Healthineers AG XETRA:SHL	41B EUR	1.7	19.1	10.8	15.2
US	IDEXX Laboratories Inc NASDAQ:IDXX	44.5B USD	10.3	42	29.8	33
US	Becton Dickinson and Co NYSE:BDX	44B USD	2	25	9.9	16.8
US	GE Healthcare Technologies Inc NASDAQ:GEHC	31.6B USD	1.5	15.1	11	13.2

			Revenue Growth	P/S to Growth
AU	EMvision Medical Devices Ltd ASX:EMV	Average P/S: 7.5 25.6	15%	1.7
US	Abbott Laboratories NYSE:ABT	4.1	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	16	15%	1.1
US	Stryker Corp NYSE:SYK	5	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.2	7%	0.5
US	Boston Scientific Corp NYSE:BSX	5.1	11%	0.5
US	Edwards Lifesciences Corp NYSE:EW	7.6	11%	0.7
DE	Siemens Healthineers AG XETRA:SHL	1.7	5%	0.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	10.3	10%	1
US	Becton Dickinson and Co NYSE:BDX	2	-2%	N/A
US	GE Healthcare Technologies Inc NASDAQ:GEHC	1.5	5%	0.3

			Earnings Growth	PEG
AU	EMvision Medical Devices Ltd ASX:EMV	Average P/E: 32.6 Negative Multiple: -14.7	N/A	N/A
US	Abbott Laboratories NYSE:ABT	27.7	23%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	56.3	19%	3
US	Stryker Corp NYSE:SYK	38.6	30%	1.3
IE	Medtronic PLC NYSE:MDT	24.2	22%	1.1
US	Boston Scientific Corp NYSE:BSX	35.4	31%	1.1
US	Edwards Lifesciences Corp NYSE:EW	43	27%	1.6
DE	Siemens Healthineers AG XETRA:SHL	19.1	16%	1.2
US	IDEXX Laboratories Inc NASDAQ:IDXX	42	13%	3.2
US	Becton Dickinson and Co NYSE:BDX	25	35%	0.7
US	GE Healthcare Technologies Inc NASDAQ:GEHC	15.1	11%	1.4

			EBITDA Growth	EV/EBITDA to Growth
AU	EMvision Medical Devices Ltd ASX:EMV	Average EV/EBITDA: 19.7 Negative Multiple: -14.3	N/A	N/A
US	Abbott Laboratories NYSE:ABT	15.9	11%	1.4
US	Intuitive Surgical Inc NASDAQ:ISRG	42.6	23%	1.9
US	Stryker Corp NYSE:SYK	19.7	12%	1.6
IE	Medtronic PLC NYSE:MDT	13.4	8%	1.7
US	Boston Scientific Corp NYSE:BSX	20.8	18%	1.2
US	Edwards Lifesciences Corp NYSE:EW	23.6	14%	1.7
DE	Siemens Healthineers AG XETRA:SHL	10.8	10%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	29.8	11%	2.7
US	Becton Dickinson and Co NYSE:BDX	9.9	1%	9.9
US	GE Healthcare Technologies Inc NASDAQ:GEHC	11	12%	0.9

			EBIT Growth	EV/EBIT to Growth
AU	EMvision Medical Devices Ltd ASX:EMV	Average EV/EBIT: 25 Negative Multiple: -14.3	N/A	N/A
US	Abbott Laboratories NYSE:ABT	21.8	18%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	52.3	25%	2.1
US	Stryker Corp NYSE:SYK	23.9	16%	1.5
IE	Medtronic PLC NYSE:MDT	19.5	17%	1.1
US	Boston Scientific Corp NYSE:BSX	28	25%	1.1
US	Edwards Lifesciences Corp NYSE:EW	25.8	15%	1.7
DE	Siemens Healthineers AG XETRA:SHL	15.2	15%	1
US	IDEXX Laboratories Inc NASDAQ:IDXX	33	12%	2.7
US	Becton Dickinson and Co NYSE:BDX	16.8	15%	1.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	13.2	14%	0.9

EMvision Medical Devices Ltd
ASX:EMV

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

EMV Competitors Multiples
EMvision Medical Devices Ltd Competitors

See Also

Company

Help

Tools

Stocks

EMvision Medical Devices Ltd ASX:EMV

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

EMV Competitors Multiples EMvision Medical Devices Ltd Competitors

See Also

Company

Help

Tools

Stocks

EMvision Medical Devices Ltd
ASX:EMV

EMV Competitors Multiples
EMvision Medical Devices Ltd Competitors